Art of Surgerywelcomes case reports which are supposed to report new observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in the fields of medicine.

For completeness and transparency for published case reports, Art of Surgery will apply the CARE guidelines (1) as reporting standards for case reports starting from October 14, 2019. For any submission of case report after the date:

Honorary Editor-in-Chief: Gerard M. Doherty, MD

A graduate of Holy Cross and Yale School of Medicine, Dr. Doherty completed residency training at UCSF, including fellowship at the National Cancer Institute. He joined Washington University School of Medicine in 1993, and became Professor of Surgery in 2001. In 2002 he was named Head of General Surgery and Thompson Professor of Surgery at the University of Michigan, where he also served as General Surgery Program Director and Vice Chair of the Department of Surgery.

Honorary Editor-in-Chief: Monica M. Bertagnolli, MD

Dr. Bertagnolli is the Richard E. Wilson Professor of Surgery in the Field of Surgical Oncology at Harvard Medical School, and Chief of the Division of Surgical Oncology at Dana Farber/Brigham and Women’s Cancer Center (DF/BWCC). She is also a member of the Gastrointestinal Cancer and Sarcoma Disease Centers at DF/BWCC, where she collaborates with colleagues in medical oncology, radiation oncology, and pathology to treat cancer patients in a tertiary care setting.

Editor-in-Chief: Jiping Wang, MD, PhD

Dr. Wang graduated from Henan Medical University, and obtained PhD in Biostatistics from University of Pittsburgh. He served as a biostatistician at National Surgical Adjuvant Breast and Bowel Project (NSABP) upon his graduation. During the surgical residency training at State University of New York at Buffalo, he was appointed as assistant professor at Department of Biostatistics. Subsequently, Dr. Wang obtained Fineberg Fellowship training at Brigham and Women’s Hospital, Massachusetts General Hospital and Dana Farber Cancer Institute.

Editorial Board Member: Chandrajit P. Raut, MD, MSc (Sarcoma)

Chandrajit P. Raut, M.D., M.Sc. is an Associate Professor of Surgery at Harvard Medical School, Associate Surgeon in the Division of Surgical Oncology at Brigham and Women’s Hospital, and Surgery Director of the Center for Sarcoma and Bone Oncology at Dana-Farber Cancer Institute. A graduate of Stanford University (BA/BS), University of Oxford (MSc), and Harvard Medical School (MD), he completed his general surgery residency at Massachusetts General Hospital and surgical oncology fellowship at M.D. Anderson Cancer Center.

Editorial Board Member: Thomas E. Clancy, MD (Pancreas)

Thomas E. Clancy M.D. is Associate Chief of the Division of Surgical Oncology at Brigham and Women’s Hospital, Surgical Director for Gastrointestinal Cancer at the Dana-Farber/Brigham and Women’s Cancer Center, Co-Director of the Pancreas and Biliary Tumor Program at the Dana-Farber/Brigham and Women’s Cancer Center, and an Assistant Professor of Surgery at Harvard Medical School. Dr. Clancy is a graduate of Holy Cross College and received his medical degree from Harvard Medical School. He completed general surgical residency at Brigham and Women’s Hospital and surgical oncology fellowship at Brigham and Women’s Hospital and Dana-Farber Cancer Institute.

Editorial Board Member: Dennis P. Orgill, MD, PhD (Plastic Surgery)

Dennis Orgill, M.D., Ph.D. is a Professor of Surgery at Harvard Medical School (HMS) who specializes in complex adult reconstructive surgery at Brigham and Women’s Hospital (BWH). Dr. Orgill grew up in northern California and studied Bioengineering at UC Berkeley. He then joined the Harvard-MIT Health Sciences and Technology program as a graduate student where he worked with Dr. Ioannis Yannas at MIT and Dr. John Burke at the Shriners Burn Hospital on developing an artificial skin for burn victims. Today, this technology is the leading skin replacement method used throughout the world and is the core product of Integra LifeSciences Corporation. Dr. Orgill completed medical school at HMS and residencies in surgery and plastic surgery with most of his time at BWH. His research experience provided a foundation for his career where he has continued to improve skin replacement and wound healing therapies.

Douglas S. Smink, MD, MPH is an Associate Professor in Surgery at Harvard Medical School and a minimally invasive general surgeon at Brigham and Women’s Hospital. His clinical interests include abdominal wall hernias, foregut surgery, and biliary tract disease. Dr. Smink trained in general surgery at Brigham and Women’s Hospital in Boston and in minimally invasive surgery at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire.

Dr. Tavakkoli is a minimally invasive and bariatric surgeon at Brigham and Women’s Hospital and Associate Professor of Surgery at Harvard Medical School. He is the co-director of the Center for Weight Management and Metabolic Surgery as well as the director of Minimally Invasive Surgery fellowship. He received his medical degree from The London Hospital Medical College in England and became a Fellow of the Royal College of Surgeons of England (FRCS) before moving to Boston and finishing his surgical residency at the Brigham and Women’s Hospital and subsequently completing the Harvard Advanced Minimally Invasive fellowship.

News

Art of Surgery is an internationally peer reviewed journal for medical students, residents, fellows and attendings in the field of surgery, and scientists and researchers in the biomedical field who wish to transform surgical education, practice and research, with the mission to better serve our patients via educating and training the next generation of surgeons and promote innovative research.